Cargando…
Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression
Octyl gallate (OG) is an antioxidant commonly used in food, although there is no definition of its acceptable daily intake. There are reports in vitro and in vivo showing that food additives and drugs can alter lipid metabolism. Lipid droplet accumulation in hepatic cells is one of the main findings...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415935/ https://www.ncbi.nlm.nih.gov/pubmed/32788910 http://dx.doi.org/10.17179/excli2020-2214 |
_version_ | 1783569232937615360 |
---|---|
author | Lima, Kelly Goulart Schneider Levorse, Vitor Giancarlo Rosa Garcia, Maria Claudia de Souza Basso, Bruno Pasqualotto Costa, Bruna Antunes, Gessica Luana Luft, Carolina Haute, Gabriela Viegas Leal Xavier, Léder Donadio, Márcio Vinícius Fagundes Rodrigues de Oliveira, Jarbas |
author_facet | Lima, Kelly Goulart Schneider Levorse, Vitor Giancarlo Rosa Garcia, Maria Claudia de Souza Basso, Bruno Pasqualotto Costa, Bruna Antunes, Gessica Luana Luft, Carolina Haute, Gabriela Viegas Leal Xavier, Léder Donadio, Márcio Vinícius Fagundes Rodrigues de Oliveira, Jarbas |
author_sort | Lima, Kelly Goulart |
collection | PubMed |
description | Octyl gallate (OG) is an antioxidant commonly used in food, although there is no definition of its acceptable daily intake. There are reports in vitro and in vivo showing that food additives and drugs can alter lipid metabolism. Lipid droplet accumulation in hepatic cells is one of the main findings in the unregulated lipid metabolism and is strongly related to the development of nonalcoholic fatty liver disease (NAFLD). In this study, we investigated the effects of OG on lipid metabolism in the hepatocellular carcinoma cell line (HepG2). The results have shown, for the first time, that treatment with OG increased the overall amount of lipids, the triglyceride concentration, the lipid droplet area, and SREBP-1c and PPAR-γ gene expression. Taken together, the findings indicate that OG induces lipid droplet accumulation in HepG2 cells through the regulation of SREBP-1c and PPAR-γ gene expression without involving mTOR/S6K1 and may contribute to NAFLD when used as a food additive. |
format | Online Article Text |
id | pubmed-7415935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Leibniz Research Centre for Working Environment and Human Factors |
record_format | MEDLINE/PubMed |
spelling | pubmed-74159352020-08-11 Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression Lima, Kelly Goulart Schneider Levorse, Vitor Giancarlo Rosa Garcia, Maria Claudia de Souza Basso, Bruno Pasqualotto Costa, Bruna Antunes, Gessica Luana Luft, Carolina Haute, Gabriela Viegas Leal Xavier, Léder Donadio, Márcio Vinícius Fagundes Rodrigues de Oliveira, Jarbas EXCLI J Original Article Octyl gallate (OG) is an antioxidant commonly used in food, although there is no definition of its acceptable daily intake. There are reports in vitro and in vivo showing that food additives and drugs can alter lipid metabolism. Lipid droplet accumulation in hepatic cells is one of the main findings in the unregulated lipid metabolism and is strongly related to the development of nonalcoholic fatty liver disease (NAFLD). In this study, we investigated the effects of OG on lipid metabolism in the hepatocellular carcinoma cell line (HepG2). The results have shown, for the first time, that treatment with OG increased the overall amount of lipids, the triglyceride concentration, the lipid droplet area, and SREBP-1c and PPAR-γ gene expression. Taken together, the findings indicate that OG induces lipid droplet accumulation in HepG2 cells through the regulation of SREBP-1c and PPAR-γ gene expression without involving mTOR/S6K1 and may contribute to NAFLD when used as a food additive. Leibniz Research Centre for Working Environment and Human Factors 2020-07-06 /pmc/articles/PMC7415935/ /pubmed/32788910 http://dx.doi.org/10.17179/excli2020-2214 Text en Copyright © 2020 Lima et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited. |
spellingShingle | Original Article Lima, Kelly Goulart Schneider Levorse, Vitor Giancarlo Rosa Garcia, Maria Claudia de Souza Basso, Bruno Pasqualotto Costa, Bruna Antunes, Gessica Luana Luft, Carolina Haute, Gabriela Viegas Leal Xavier, Léder Donadio, Márcio Vinícius Fagundes Rodrigues de Oliveira, Jarbas Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression |
title | Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression |
title_full | Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression |
title_fullStr | Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression |
title_full_unstemmed | Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression |
title_short | Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression |
title_sort | octyl gallate induces hepatic steatosis in hepg2 cells through the regulation of srebp-1c and ppar-gamma gene expression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415935/ https://www.ncbi.nlm.nih.gov/pubmed/32788910 http://dx.doi.org/10.17179/excli2020-2214 |
work_keys_str_mv | AT limakellygoulart octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT schneiderlevorsevitorgiancarlo octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT rosagarciamariaclaudia octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT desouzabassobruno octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT pasqualottocostabruna octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT antunesgessicaluana octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT luftcarolina octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT hautegabrielaviegas octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT lealxavierleder octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT donadiomarcioviniciusfagundes octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression AT rodriguesdeoliveirajarbas octylgallateinduceshepaticsteatosisinhepg2cellsthroughtheregulationofsrebp1candppargammageneexpression |